scispace - formally typeset
M

Maria de la Fuente

Researcher at Group Health Research Institute

Publications -  91
Citations -  3866

Maria de la Fuente is an academic researcher from Group Health Research Institute. The author has contributed to research in topics: Thrombin & Cancer. The author has an hindex of 30, co-authored 91 publications receiving 3211 citations. Previous affiliations of Maria de la Fuente include Case Western Reserve University & University of London.

Papers
More filters
Journal ArticleDOI

Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.

TL;DR: It is suggested that administering autologous platelet‐rich clots may be beneficial to the treatment of tendon injuries by inducing cell proliferation and promoting the synthesis of angiogenic factors during the healing process.
Journal ArticleDOI

Chitosan-based nanostructures: a delivery platform for ocular therapeutics.

TL;DR: The results collected up until now suggest the potential of the delivery platform based on the polysaccharide chitosan and the subsequent need of a full preclinical evaluation in order to satisfy the specific regulatory demands of this mode of administration.
Journal ArticleDOI

Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy

TL;DR: Evidence is given of the potential of HA-CS nanoparticles for the targeting and further transfer of genes to the ocular surface.
Journal ArticleDOI

Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities.

TL;DR: Results indicate that administration of fibrin matrices is a safe and easy strategy that may open new avenues for enhancing tissue healing and remodelling and influences the process of regeneration in clinical situations characterised by a poor healing outcome.
Journal ArticleDOI

Reciprocal actions of platelet-secreted TGF-beta1 on the production of VEGF and HGF by human tendon cells.

TL;DR: The balance between TGF-&bgr;1 and the pools of platelet-secreted molecules may have important therapeutic implications in the control of angiogenesis and fibrosis.